2018 marked the most important milestone of our program to date, the launch of
the Maternal Health
Synapse. We believe that the Maternal Health Synapse has the
potential to be game-changing in the field of maternal and neonatal health. An
approach that has already shown huge success with the Patient Focused Medicines
Development initiative, Synapse maps and categorises maternal health
initiatives, actors, organisations and knowledge on a global level within one
platform.
Joining the Maternal Health Synapse will help
make your initiative visible to others, and will also enable you to find the
right partner, organisation, initiative or resource, and showcase achievements
and best practices. Currently in beta, Synapse is the
culmination of several years of work including on other health issues, and with
your feedback will continue to be improved and developed in the coming months.
This year was also an opportunity for the Alliance for Maternal Health Equality
members to take a step back and refocus the program strategy. Through a task
force, working sessions and with the support of experts, we defined a joint
Policy Ask which we also opened for public consultation. The Policy Ask for
the Alliance is: free antenatal care for all women in Europe on the basis of
the 2016 World Health Organization (“WHO”) Recommendations on Antenatal Care
for a Positive Pregnancy Experience.
Safe Motherhood Week 2018 was the biggest yet with a launch at the World
Convergences Forum in Paris. We continued our #MakeMotherhoodCount campaign to
collect stories from real women and their families on their motherhood
experience, with a special focus on Romania. Our campaign reached over half a
million people globally and next year we seek to make an even greater impact by
collaborating with more organisations via Synapse.
Looking ahead to 2019, we will begin an important collaboration as part of the
Innovative Medicines Initiative (IMI) project ConcePTION, to provide improved
tools and methods to generate more valuable, reliable and timely information to
HCPs and pregnant and lactating women about medication use during and after
pregnancy. We look forward to bringing our expertise in building collective
partnerships for collective impact to this important topic.